Qingyun Mei
Overview
Explore the profile of Qingyun Mei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kong F, Zhao L, Wang N, Zhang D, Wang Z, Mei Q, et al.
Recent Pat Anticancer Drug Discov
. 2024 Jan;
19(2):165-175.
PMID: 38214356
Introduction: Maintenance therapy aimed to strengthen the first-line chemotherapy and improve quality of life is needed for gastric cancer (GC). Currently, many clinical studies have confirmed the important role of...
2.
Li L, Liang Y, Yu M, Zhao L, Mei Q, Yu Y, et al.
Cancer Med
. 2023 Mar;
12(10):11097-11106.
PMID: 36880420
Background: As one of the most aggressive neuroendocrine tumors, small cell lung cancer (SCLC) has the most disappointing prognosis of all lung cancers. Although SCLC responds well to initial chemotherapy,...
3.
Zhao L, Zhang J, Wang N, Zhang D, Wang Z, Yu Y, et al.
Anticancer Drugs
. 2023 Feb;
34(9):979-984.
PMID: 36729098
Immune ch eckpoint inhibitors (ICIs) represent a milestone in advanced nonsmall cell lung cancer (NSCLC). Nevertheless, NSCLC with known oncogenic drivers has been overlooked in most studies evaluating anti-programmed death-1/programmed...
4.
Kong F, Wang Z, Wang N, Zhao L, Mei Q, Yu Y, et al.
Front Oncol
. 2022 Jul;
12:888651.
PMID: 35875071
Objective: The present study aimed to explore the effectiveness of acupuncture combined with antiemetic drugs in prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) among breast cancer patients receiving...
5.
Zhao L, Mei Q, Yu Y, Wang N, Zhang D, Liao D, et al.
Front Oncol
. 2022 Jun;
12:894214.
PMID: 35707347
Great progress has been made in the treatment of driver gene-positive Non- Small Cell Lung Cancer (NSCLC) in recent years. RET fusion was seen in 0.7% to 2% of NSCLC...
6.
Wang N, Mei Q, Wang Z, Zhao L, Zhang D, Liao D, et al.
Front Oncol
. 2022 Jun;
12:889017.
PMID: 35692796
Gastric cancer is an intractable malignant tumor that has the fifth highest morbidity and the third highest mortality in the world. Even though various treatment options did much to ameliorate...
7.
Liao D, Yu Y, Mei Q, Wang Z, Li X, Jia Y, et al.
Onco Targets Ther
. 2021 Aug;
14:4477-4484.
PMID: 34429612
Malignant pleural mesothelioma (MPM) represents the uncommon cancer originating from pleural mesothelial cells, which is associated with dismal prognostic outcome. According to CheckMate-743 results, nivolumab plus ipilimumab has been approved...